By LSE RNS
Date: Monday 30 Mar 2026
(Sharecast News) - GSK drug Exdensur has been approved in China for the treatment of asthma, the blue chip announced on Monday.
| Vet prescription charges to be capped in sector ... | 24-Mar-2026 | ShareCast |
| Pets at Home shares jump on FY outlook despite l... | 28-Jan-2026 | ShareCast |
| Total Voting Rights | 02-Jan-2026 | ShareCast |
| Appointment of CEO | 23-Dec-2025 | ShareCast |
| Pets at Home appoints former Waitrose MD as chie... | 23-Dec-2025 | ShareCast |
| Director/PDMR Shareholding | 30-Mar-2026 | 07:35 | RNS |
| Total Voting Rights | 03-Mar-2026 | 07:00 | RNS |
| Transaction in Own Shares | 27-Feb-2026 | 07:00 | RNS |
| Transaction in Own Shares | 26-Feb-2026 | 07:00 | RNS |
| Transaction in Own Shares | 25-Feb-2026 | 07:00 | RNS |
| Retail sector to dominate City results | 24-Mar-2014 | The Scotsman |
| Pets at Home and Poundland make market debuts | 13-Mar-2014 | The Scotsman |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 178.40p |
| Change Today | 2.00p |
| % Change | 1.13 % |
| 52 Week High | 273.20 |
| 52 Week Low | 173.70 |
| Volume | 1,440,012 |
| Shares Issued | 448.40m |
| Market Cap | £799.94m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 1 |
| Neutral | 2 |
| Sell | 3 |
| Strong Sell | 0 |
| Total | 11 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 04-Dec-25 | 05-Jun-25 |
| Paid | 09-Jan-26 | 16-Jul-25 |
| Amount | 4.70p | 8.30p |
| Time | Volume / Share Price |
| 16:47 | 7,024 @ 176.64p |
| 16:29 | 1 @ 178.10p |
| 16:29 | 1 @ 177.80p |
| 16:29 | 1 @ 177.80p |
| 16:29 | 2 @ 178.10p |
You are here: research